The role of EUS and MRI in rectal cancer staging
The role of EUS and MRI in rectal cancer staging
复制标题
DOI：
10.1016/j.suronc.2007.10.038
复制
发表时间：
2007-12-01
影响因子：
2.3
通讯作者：
Dionigi, R.
中科院分区：
文献类型：
--
作者：
Rovera, F.;Dionigi, G.;Dionigi, R.
直肠癌仍然是世界上最常见的肿瘤之一。其预后主要取决于早期诊断和准确的分期评估，以选择最有效的治疗方法。近年来，新的和有前途的技术已经被提出，现在可以在日常实践中使用。每个直肠癌患者都应该单独考虑，选择适合于单个临床病例的诊断性预处理检查，主要与肿瘤和可用的仪器有关。临床医生必须了解这些技术的有效性，并了解肿瘤分期错误的任何原因，以降低使用不当和分期不准确的风险。(c)2007爱思唯尔有限公司保留所有权利。
Rectal cancer continues to be one of the most common tumors worldwide. Its prognosis mainly depends on early diagnosis and precise stage evaluation in order to choose the most effective treatment. In recent years, new and promising technologies have been proposed and are now available in daily practice.Each rectal cancer patient should be considered individually, choosing the diagnostic pretreatment exams that are appropriate for that single clinical case mainly related to the tumor and the available instruments. Clinicians must be informed about the efficacy of these technologies and be aware of any cause of mistake in tumor staging in order to reduce the risk of both improper use and inaccurate staging. (c) 2007 Elsevier Ltd. All rights reserved.